1 / 48

Rapid Sequence Intubation

Rapid Sequence Intubation. Delon F.P. Brennen , MD MPH Pediatric Emergency Medicine Morehouse School of Medicine. Outline. Definition Indications Method. Definition.

thuy
Download Presentation

Rapid Sequence Intubation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rapid Sequence Intubation Delon F.P. Brennen, MD MPH Pediatric Emergency Medicine Morehouse School of Medicine

  2. Outline • Definition • Indications • Method

  3. Definition • The induction of a state of unconsciousness with complete neuromuscular paralysis to achieve intubation without interposed mechanical ventilation in efforts to facilitate the procedure and minimize risks of gastric aspiration

  4. Indications • Failure of airway maintenance/protection - lost or diminished gag reflex • Failure of oxygenation/ventilation - asthma, aspiration, pneumonia • Anticipated clinical course - multiple trauma, head injured - intoxication, air transport

  5. Method (6P’s) • Preparation: T-10mins • Positioning • Preoxygenation: T-5mins • Premedication: T-3mins • Paralysis: T-1min • Placement of tube: T-0mins • Post management

  6. Preparation • Evaluate • LEMON • Equipment Check • Positioning • Drug Selection • IV’s, monitor, oximetry • Ancillary Staff • Anticipate alternative airway maneuver

  7. LEMON • LEMON • L-Look • E-Evaluate • M-Mallampati • O-Obstruction • N-Neck mobility

  8. Preoxygenation • 100% O2 for 5 minutes or 5 vital capacity breaths can theoretically permit 3-5 minutes of apnea before desaturation to less than 90% occurs • NOT Positive Pressure Ventilation • If possible

  9. Premedication • Goal • blunt the patient’s physiologic responses to intubation • Which are ? • bradycardia • hypoxemia • cough/gag reflex • increases in intracranial, intraocular, and intragastric pressures

  10. Premedication • Lidocaine • Opioid • Atropine • Defasciculating doses “priming”

  11. Lidocaine • Thought to blunt the rise in ICP associated with airway manipulation and the use of depolarizing neuromuscular blocking agents • Dose: • 1.5 - 3 mg/kg (3 mins prior to intubation)

  12. Atropine • Minimize vagal effects, bradycardia, secretions • Infants and children < 8 yrs may develop profound bradycardia during intubation • 0.02 mg/kg (minimum 0.1 mg IV, max 1 mg) 3 minutes prior to intubation

  13. Defasciculating Doses • Decreases muscle fasiculations caused by the depolarizing agents (succinylcholine) • Attenuates rise in intracranial pressure • Agents - non-depolarizing blocking agents (vecuronium, pancuronium, etc.) • Usually 1/10 of standard dose

  14. Sedation • Sedative agents administered at doses capable of producing unconsciousness with little or no cardiovascular effects • No ideal agent exists • Sedation should nearly always be used when paralyzing the patient

  15. Sedation • Barbiturates/hypnotics • Non-barbiturate • Neuroleptics • Opiates • Benzodiazepines

  16. Barbiturates/Hypnotics • Thiopental (Pentothal), Methohexital (Brevital) • Short onset - 10-20secs, • Duration - 5-10 mins • May reduce ICP, cerebro-protective • Histamine release, hypotension, bronchospasm

  17. Barbiturates/Hypnotics • Etomidate (Amidate) • nonbarbiturate hypnotic • Rapid onset, short duration • Decreases ICP/IOP • Minimal hemodynamic effects • No histamine release • Increases seizure threshold

  18. Etomidate • No malignant hyperthermia reported • Watch for myoclonus, vomiting • May decrease cortisol synthesis (adrenal insufficiency) • Dose 0.3 mg/kg IV

  19. Barbiturates/Hypnotics • Propofol (Diprivan) • sedative hypnotic • Extremely rapid onset (10 sec), • Duration of 10-15 minutes • Decreases ICP, Can cause profound hypotension • Dose 1-3 mg/kg IV for induction • Dose: 100-200 mcg/kg/min for maintenance

  20. Ketamine • Ketamine • dissociative anesthetic, not a sedative • Rapid onset (1-2mins), short duration (~15mins) • Potent bronchodilator, useful in asthmatics • Increases ICP, IOP, IGP, (beware in head injuries) • Increases bronchial secretions • “Emergence” phenomenon • rarely in children <10 yrs , common in adults • Dose: 1-2 mg/kg

  21. Opiates

  22. Fentanyl • Rapid onset (<1 min), long duration - 30 min • Does not release histamine • May decrease tachycardia and hypertension associated with intubation • Seizures and chest wall rigidity • Can be reversed with Naloxone • Dose: 2-10 mcg/kg IV

  23. Morphine Sulfate • Longer onset (3-5) minutes and duration (2-6) hours • May not blunt the rise in ICP, hypertension and tachycardia as well as fentanyl • Histamine release • Dose 0.1-0.2 mg/kg IV

  24. Benzodiazepines

  25. Benzodiazepines • Midazolam, Diazepam, Lorazepam • Provide excellent amnesia and sedation • Broad dose-response relationship • Reversed with Flumazenil • Doses required are higher for RSI than for general sedation

  26. Midazolam • Slower onset (3-5) min than the barbiturate/hypnotic agents • Considered short-acting (30-60 min) • Does not increase ICP • Causes respiratory and cardiovascular depression • Dose: 0.1-0.4mg/kg IV

  27. Diazepam and Lorazepam • Moderate/long acting agents • Longer onset time than midazolam • May be more beneficial post-intubation for sedation

  28. Paralysis

  29. Neuromuscular Blocking Agents • Chemical paralysis facilitates intubation by allowing visualization of the vocal cords and optimizing intubating condition • Only CONTRAINDICATION is anticipated difficult airway • Mallampati Class (I-IV) • Thyromental Distance

  30. Depolarizing Agents • Exert their affect by binding with acetylcholine receptors at the neuromuscular junction, causing sustained depolarization of the muscle cell

  31. Nondepolarizing • Bind to acetylcholine receptors in a competitive, non-stimulatory manner, no receptor depolarization • Histamine release • Reversed with edrophonium or neostigmine • Caution with myasthenia gravis

  32. Agents • Depolarizing agents • Succinylcholine (Anectine) • Nondepolarizing Agents • Pancuronium (Pavulon) • Vecuronium (Norcuron) • Atracurium (Tracrium) • Rocuronium (Zemuron) • Mivacurium (Mivacron)

  33. Succinylcholine • Gold standard for >50 years • Stimulates nicotinic/muscarinic cholinergic receptors • Onset 45 secs, duration 8-10 mins • Dose: Children 2.0 mg/kg IV • (adults 1.5 mg/kg IV) • Inactivated by pseudocholinesterase

  34. Succinylcholine cont • Prolonged paralysis seen with: • Pregnancy • Liver disease • Malignancies • Cytotoxic drugs • Certain antibiotics • Cholinesterase inhibitors • Organophosphate poisoning

  35. Succinylcholine • Adverse reactions • Muscle fasiculations • Hyperkalemia • Bradycardia • Prolonged neuromuscular blockade • Trismus • Malignant hyperthermia

  36. Depolarizing Agents • Muscle fasiculations • Thought to increase ICP/IOP/IGP • Causes muscle pain • Minimized by “priming” dose of non-depolarizing NMB • Hyperkalemia • Average increase in potassium of 0.5-1 mEq/L • Burns, crush injuries, spinal cord injuries, neuromuscular disorders, chronic renal failure

  37. Depolarizing agents • Bradycardia • Most common in kids <10 yrs 2o higher vagal tone • Especially w/ repeated doses of succinylcholine • Premedicate with atropine

  38. Depolarizing Agents • Malignant hyperthermia • From excessive calcium influx through open channels • Genetic predisposition • Rapid rise in temperature, rhabdomyolysis, muscle rigidity, DIC • 60% mortality • Treatment: IV Dantrolene

  39. Depolarizing Agents • Trismus (Masseter spasm) • Usually in children • Unknown cause • Treat with a nondepolarizing NMB

  40. Pancuronium • Slow onset (1-5 min) • Long-acting agent (45-90 min) • Renal excretion • Vagolytic tachyarrythmias common • Dose: 0.10-0.15 mg/kg IV

  41. Vecuronium • Onset of 1-4 min • Duration of 30-60 min • Hypotension may occur from loss of venous return and sympathetic blockade • Mostly biliary excretion • Dose 0.1 mg/kg • “priming dose” 0.01 mg/kg

  42. Rocuronium • Shortest onset of the nondepolarizing agents (1-3 min) • Duration 30-45 min • Tachycardia can occur • Dose: 0.6-1.2 mg/kg (1mg/kg)

  43. Placement of Tube • Allow medications to work and assure complete neuromuscular blockade of the patient • Maintain Sellick maneuver until cuff inflated • Ventilate with bag-valve mask if unsuccessful • Additional doses of sedatives/NMB may be necessary • Confirm tube placement

  44. Post Intubation Management • Secure tube • Continuous pulse oximetry • Reassess vital signs frequently • Obtain chest x-ray, ABG • Restrain (physical/chemical)patient • Consider long term sedation

  45. Questions?? Thank You!

More Related